Literature DB >> 18422568

How do patients with parkinsonism present? A clinicopathological study.

D R Williams1, A J Lees.   

Abstract

BACKGROUND: The early clinical features of neurodegenerative parkinsonism can be subtle and often coexist with autonomic, sensory and psychic symptoms, making accurate early diagnosis challenging.
METHODS: We retrospectively assessed the initial, clinical presentation and referral patterns of 494 patients with a pathological diagnosis of parkinsonism (344 with Parkinson's disease (PD), 89 with progressive supranuclear palsy (PSP) and 61 with multiple system atrophy (MSA)) archived at the Queen Square Brain Bank, London.
RESULTS: Forty-four per cent of all patients were initially referred to a neurologist. Of those with PD, 28% were referred to a general physician, and approximately 5% each to orthopaedic surgeons, urologists, psychiatrists and rheumatologists. Pain was common in those not initially referred to neurologists and most lacked early tremor, rigidity and bradykinesia. More PSP patients were initially referred to ophthalmologists than in PD (9 vs 1%, chi(2)P < 0.001) and more MSA patients were referred to a urologist or gynaecologist than in PD (21 vs 5%, chi(2)P < 0.001). In PD a frozen shoulder, degenerative spine disease and benign prostatic hypertrophy were the most common early diagnoses. In PSP, the most common misdiagnosis was PD, followed by vascular parkinsonism and degenerative spinal disease. This was similar in MSA, but bladder outlet obstruction and idiopathic vocal cord palsy were other initial diagnoses.
CONCLUSION: The early clinical manifestations of PD, PSP and MSA are protean and often non-specific, leading to diverse specialist referrals. When diagnoses, such as frozen shoulder and cervical spondylosis, benign prostatic hypertrophy or unstable bladder and depression are made, specialists should consider the possibility of early parkinsonism and look carefully for additional subtle motor abnormalities.

Entities:  

Mesh:

Year:  2008        PMID: 18422568     DOI: 10.1111/j.1445-5994.2008.01635.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  9 in total

1.  Use of ibuprofen and risk of Parkinson disease.

Authors:  Xiang Gao; Honglei Chen; Michael A Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2011-03-02       Impact factor: 9.910

2.  Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-12

3.  Primary lateral sclerosis as progressive supranuclear palsy: diagnosis by diffusion tensor imaging.

Authors:  Elizabeth A Coon; Jennifer L Whitwell; Clifford R Jack; Keith A Josephs
Journal:  Mov Disord       Date:  2012-04-19       Impact factor: 10.338

4.  Tau protein and beta-amyloid(1-42) CSF levels in different phenotypes of Parkinson's disease.

Authors:  Hana Přikrylová Vranová; Jan Mareš; Petr Hluštík; Martin Nevrlý; David Stejskal; Jana Zapletalová; Radko Obereigneru; Petr Kaňovský
Journal:  J Neural Transm (Vienna)       Date:  2011-09-04       Impact factor: 3.575

Review 5.  Parkinsonian syndromes.

Authors:  David R Williams; Irene Litvan
Journal:  Continuum (Minneap Minn)       Date:  2013-10

6.  Is the loss of thalamostriatal neurons protective in parkinsonism?

Authors:  Sheila V Kusnoor; E Chris Muly; James I Morgan; Ariel Y Deutch
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

Review 7.  Recent developments in multiple system atrophy.

Authors:  Gregor K Wenning; Nadia Stefanova
Journal:  J Neurol       Date:  2009-05-27       Impact factor: 4.849

8.  Conventional Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Disorders: A Meta-Analysis.

Authors:  Will Lee
Journal:  Mov Disord Clin Pract       Date:  2020-09-14

9.  The evidence for urodynamic investigation of patients with symptoms of urinary incontinence.

Authors:  Peter F Rosier
Journal:  F1000Prime Rep       Date:  2013-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.